skip to primary navigationskip to content

Owlstone Medical Opens New Breath Biopsy Lab

last modified Mar 23, 2017 08:59 AM
Tony Blair officially opened the new high volume lab in Cambridge last week

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the company’s new high volume clinical laboratory.

During the visit, Mr Blair learned more about the company’s Breath Biopsy® technology and its mission to save 100,000 lives and $1.5 billion in healthcare costs. He was also given a tour of Owlstone Medical headquarters including the new clinical lab and other research facilities.

The opening of a new clinical lab with increased capacity enables Owlstone Medical to offer high quality and high throughput Biomarker Services to academics, clinicians, pharmaceutical companies and CROs to identify novel breath biomarkers for disease diagnostics as well as precision medicine applications including therapeutic response, patient stratification and outcome prediction.

The clinical lab also provides VOC biomarker analysis of breath samples and other biospecimens from the on-going clinical trials in Owlstone Medical’s own clinical pipeline: early detection of lung cancer (LuCID), colorectal cancer (InTERCEPT) and treatment stratification in asthma (STRATA).

Billy Boyle, co-founder and CEO at Owlstone Medical commented: “Our new high volume clinical lab follows the successful commercial launch of our Biomarker Services earlier this year and the announcement of our first clinical and pharma customers. Having a state-of-the-art and globally unique capability allows us to increase capacity to handle large service projects as well as support our ongoing clinical trials.”

Tony Blair said: “I congratulate Owlstone Medical on the opening of its new clinical lab. It was a pleasure to meet the dedicated staff of this successful, dynamic company, united in their clear vision to save lives. The breath biopsy technology has huge potential to lead to great improvements in healthcare, and I wish the team every success in developing a company that will become a leader in next generation diagnostics.”

Mr Blair also visited ideaSpace West to meet some other Cambridge founders.

To find out more about Owlstone Medical visit: www.owlstonemedical.com

RSS Feed Latest news

PragmatIC named Future Planet “Company of the Year”

May 26, 2017

Award recognises PragmatIC's potential not only revolutionise the electronics market, but change the world.

Metail announces partnership with fast growing online fashion retailer, Princess Polly

May 26, 2017

Shaking up the Australian online retail market with virtual 'try before you buy'

'Best in Class' Win for GeoSpock

May 23, 2017

GeoSpock Founder Dr Steve Marsh picked up prize in 'UK Data Entrepreneur Category' of the Data 50 Awards

GeoSpock Named Festival of Media "Emerge Start-up of the Year"

May 10, 2017

Fierce competition at the final pitch-off

IntelliSense.io Win Best Digital Solution Award

May 09, 2017

International recognition for 'Pit to Port' platform

View all news